 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 September 1993 | Volume 119 Issue 5 | Pages 383-390
Objective: To determine the incidence of second primary cancers developing in patients surviving free of cancer for 2 or more years after treatment for small-cell lung cancer and to assess the potential effect of smoking cessation.
Design: Retrospective review of 540 patients from a single institution with a median follow-up of 6.1 years.
Setting: A single government institution (the National Cancer Institute).
Patients: Consecutive sample of 540 patients with histologically confirmed small-cell lung cancer treated from 1973 through 1989 on therapeutic clinical trials.
Measurements: The relative risk for second primary cancers and death were calculated in patients who remained free of cancer for 2 years after initiation of therapy. The relation of these end points to smoking history was also determined.
Results: Fifty-five patients (10%) were free of cancer 2 years after initiation of therapy. Eighteen of these patients developed one or more second primary cancers, including 13 who developed second primary non- small-cell lung cancer. The risk for any second primary cancer compared with that in the general population was increased four times (relative risk, 4.4; 95% CI, 2.5-7.2), with a relative risk of a second primary non- small-cell lung cancer of 16 (CI, 8.4-27). Forty-three patients discontinued smoking within 6 months of starting treatment for small-cell lung cancer, and 12 continued to smoke. In those who stopped smoking at time of diagnosis, the relative risk of a second lung cancer was 11 (CI, 4.4 to 23), whereas, in those who continued to smoke, it was 32 (CI, 12 to 69).
Conclusions: Patients with small-cell lung cancer who survive cancer-free for more than 2 years have a significantly increased risk for development of a second primary smoking-related cancer. Cigarette smoking cessation after successful therapy is associated with a decrease in risk for a second smoking-related primary cancer.
Author and Article Information
From the National Cancer Institute, National Naval Medical Center, and Uniformed Services University of the Health Sciences, Bethesda, Maryland.
ARTICLE
Smoking Cessation after Successful Treatment of Small-Cell Lung Cancer Is Associated with Fewer Smoking-related Second Primary Cancers
Requests for Reprints: Bruce E. Johnson, MD, National Cancer Institute-Navy Medical Oncology Branch, Building 8, Room 5101, National Naval Medical Center, Bethesda, MD 20889-5101.
This article has been cited by other articles:
|
|
 |
|
  J. Rubins, M. Unger, and G. L. Colice Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 355S - 367S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Walker, D. J. Vidrine, E. R. Gritz, R. J. Larsen, Y. Yan, R. Govindan, and E. B. Fisher Smoking Relapse during the First Year after Treatment for Early-Stage Non-Small-Cell Lung Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2370 - 2377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Matsui, T. Sawa, H. Suzuki, K. Nakagawa, N. Okamoto, T. Tada, T. Nagano, and N. Masuda Relapse of Stage I Small Cell Lung Cancer Ten or More Years after the Start of Treatment Jpn. J. Clin. Oncol., July 1, 2006; 36(7): 457 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. R. Khuri, J. J. Lee, S. M. Lippman, E. S. Kim, J. S. Cooper, S. E. Benner, R. Winn, T. F. Pajak, B. Williams, G. Shenouda, et al. Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients. J Natl Cancer Inst, April 5, 2006; 98(7): 441 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawaguchi, A. Matsumura, K. Iuchi, S. Ishikawa, H. Maeda, S. Fukai, H. Komatsu, and M. Kawahara Second Primary Cancers in Patients with Stage III Non-Small Cell Lung Cancer Successfully Treated with Chemo-radiotherapy Jpn. J. Clin. Oncol., January 1, 2006; 36(1): 7 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Gritz, C. Dresler, and L. Sarna Smoking, The Missing Drug Interaction in Clinical Trials: Ignoring the Obvious Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2287 - 2293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Murin Smoking Cessation Before Lung Resection Chest, June 1, 2005; 127(6): 1873 - 1875. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Tammemagi, C. Neslund-Dudas, M. Simoff, and P. Kvale Smoking and Lung Cancer Survival: The Role of Comorbidity and Treatment Chest, January 1, 2004; 125(1): 27 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Means-Markwell, R. I. Linnoila, J. Williams, P. A. Janne, F. Kaye, K. O'Neil, and B. E. Johnson Prospective Study of the Airways and Pulmonary Parenchyma of Patients at Risk for a Second Lung Cancer Clin. Cancer Res., December 1, 2003; 9(16): 5915 - 5921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M.M. Videtic, L. W. Stitt, A. R. Dar, W. I. Kocha, A. T. Tomiak, P. T. Truong, M. D. Vincent, and E. W. Yu Continued Cigarette Smoking by Patients Receiving Concurrent Chemoradiotherapy for Limited-Stage Small-Cell Lung Cancer Is Associated With Decreased Survival J. Clin. Oncol., April 15, 2003; 21(8): 1544 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. McBride, K. M. Emmons, and I. M. Lipkus Understanding the potential of teachable moments: the case of smoking cessation Health Educ. Res., April 1, 2003; 18(2): 156 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Colice, J. Rubins, and M. Unger Follow-up and Surveillance of the Lung Cancer Patient Following Curative-Intent Therapy Chest, January 1, 2003; 123(1_suppl): 272S - 283S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gariti, D. I. Rosenthal, K. Lindell, J. Hansen-Flaschen, J. Shrager, C. Lipkin, A. I. Alterman, and L. R. Kaiser Validating a Dipstick Method for Detecting Recent Smoking Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1123 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Cox, C. A. Patten, J. O. Ebbert, A. A. Drews, G. A. Croghan, M. M. Clark, T. D. Wolter, P. A. Decker, and R. D. Hurt Tobacco Use Outcomes Among Patients With Lung Cancer Treated for Nicotine Dependence J. Clin. Oncol., August 15, 2002; 20(16): 3461 - 3469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kitamoto, K. Hayakawa, N. Mitsuhashi, S. Tsuchiya, and R. Saito Redevelopment of Small Cell Lung Cancer After a Long Disease-free Period: a Case Report Jpn. J. Clin. Oncol., January 1, 2002; 32(1): 30 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. R. Khuri, E. S. Kim, J. J. Lee, R. J. Winn, S. E. Benner, S. M. Lippman, K. K. Fu, J. S. Cooper, E. E. Vokes, R. M. Chamberlain, et al. The Impact of Smoking Status, Disease Stage, and Index Tumor Site on Second Primary Tumor Incidence and Tumor Recurrence in the Head and Neck Retinoid Chemoprevention Trial Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 823 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Smythe, A. L. Estrera, S. G. Swisher, K. W. Merriman, G. L. Walsh, J. B. Putnam Jr, A. A. Vaporciyan, and J. A. Roth Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma Ann. Thorac. Surg., March 1, 2001; 71(3): 962 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Gotay, C. M. Moinpour, S. Moody-Thomas, E. R. Gritz, K. S. Albain, E. DeAntoni, L. Hansen, and P. A. Ganz Behavioral Science Research in the Cooperative Group Setting: the Southwest Oncology Group Experience J Natl Cancer Inst, September 6, 2000; 92(17): 1381 - 1387. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mimoto, K. Kiura, K. Matsuo, T. Yoshino, I. Takata, H. Ueoka, M. Kataoka, and M. Harada (-)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice Carcinogenesis, May 1, 2000; 21(5): 915 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fujisawa, T. Iizasa, Y. Saitoh, Y. Sekine, S.-i. Motohashi, T. Yasukawa, K. Shibuya, K. Hiroshima, and H. Ohwada Smoking Before Surgery Predicts Poor Long-Term Survival in Patients With Stage I Non-Small-Cell Lung Carcinomas J. Clin. Oncol., July 1, 1999; 17(7): 2086 - 2086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Multiple primary lung carcinomas J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 405 - 405. [Full Text]
|
|
|
|
|
|
T. Antakli, R. F. Schaefer, J. E. Rutherford, and R. C. Read Second Primary Lung Cancer Ann. Thorac. Surg., April 1, 1995; 59(4): 863 - 867. [Abstract] [Full Text]
|
|
Article
